Good Hygienic Practice for the Treatment of Pharma Closures Part 2

被引：0

作者：

Dueblin, Martin ^{[1
]}

机构：

[1] Y Tec GmbH, CH-4104 Oberwil, Switzerland

来源：

PHARMAZEUTISCHE INDUSTRIE | 2009年 / 71卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1417 / +

页数：4

共 50 条

[1] Good Hygienic Practice for the Treatment of Pharma Closures
Dueblin, Martin
[J]. PHARMAZEUTISCHE INDUSTRIE, 2009, 71 (07): : 1247 - 1250
[2] Investing in 'pharma' part 2
不详
[J]. ANNALS OF ONCOLOGY, 2002, 13 (06) : 812 - 812
[3] Hygienic equipment and systems - Regulations, issues, standards and good practice
Farquharson, GJ
[J]. 34TH R3-NORDIC CONTAMINATION CONTROL SYMPOSIUM, 2003, 229 : 217 - 238
[4] Pharma and Healthcare Reform, Part 2
Bush, Laura
[J]. BIOPHARM INTERNATIONAL, 2009, 22 (10) : 12 - 12
[5] Good Laboratory Practice. Part 3. Implementing Good Laboratory Practice in the Analytical Lab
Wedlich, Richard C.
Pires, Amanda
Fazzino, Lisa
Fransen, Joseph M.
[J]. JOURNAL OF CHEMICAL EDUCATION, 2013, 90 (07) : 862 - 865
[6] Comments on the GAMP good practice guide for validation of laboratory computerized systems, part 2
McDowall, R. D.
[J]. LC GC EUROPE, 2006, 19 (09) : 462 - +
[7] Good Laboratory Practice. Part 2. Recording and Retaining Raw Data
Wedlich, Richard C.
Libera, Agata E.
Pires, Amanda
Tellarini, Cassandra
[J]. JOURNAL OF CHEMICAL EDUCATION, 2013, 90 (07) : 858 - 861
[8] Drug Safety in Clinical Practice - Part 2: Psychopharmacological Treatment
Stuebner, S.
Grohmann, R.
Schmauss, M.
[J]. FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2013, 81 (12) : 715 - 729
[9] Medical treatment of type 2 diabetes (update) Recommendation for good practice
不详
[J]. DIABETES & METABOLISM, 2007, 33 (01) : XIII - S105
[10] Elements of a "good practice" Aboriginal mediation model: Part I
Kelly, Loretta
[J]. AUSTRALASIAN DISPUTE RESOLUTION JOURNAL, 2008, 19 (03): : 198 - 205

← 1 2 3 4 5 →